Skip to Content

RDY 611 (Pramipexole dihydrochloride extended-release 0. 375 mg)

Pill imprint RDY 611 has been identified as Pramipexole dihydrochloride extended-release 0. 375 mg.

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0. 375 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pramipexole dihydrochloride extended-release 0. 375 mg RDY 611
Discount Card Promo
Pramipexole dihydrochloride extended-release
RDY 611
0. 375 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Dr. Reddy's Laboratories Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.